Butyzamide |
| Catalog No.GC68819 |
Butyzamide는 경구 효능을 가진 Mpl 활성제로, Mpl은 혈소판 생성 인자 (TPO) 수용체입니다. Butyzamide는 JAK2, STAT3, STAT5 및 MAPK의 인산화 수준을 증가시킵니다. Butyzamide는 마우스 이식 실험에서 인간 혈소판 수준을 증가시킵니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1110767-45-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Butyzamide
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Butyzamide
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *